{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:03:38Z","timestamp":1773083018885,"version":"3.50.1"},"reference-count":127,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T00:00:00Z","timestamp":1442534400000},"content-version":"unspecified","delay-in-days":9271,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. j. neurol. sci."],"published-print":{"date-parts":[[1990,5]]},"abstract":"<jats:title>ABSTRACT:<\/jats:title><jats:p>This is a review of reserpine, haloperidol, and various phenothiazines that produce parkinsonism and other movement disorders. The by-products of illicit meperidine synthesis, MPTP and its more sinister companion, MPP, are also discussed. Movement disorders, transient or fixed, frank parkinsonism and\/or dyskinesia, due to a variety of other medications and toxic agents are included. These are methanol, lithium, methyldopa, antimetabolites, antidepressants, sympathomimetic anorexiants, some types of antihistamines, and various combinations of agricultural chemicals.<\/jats:p>","DOI":"10.1017\/s0317167100030389","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T11:41:03Z","timestamp":1469706063000},"page":"155-162","source":"Crossref","is-referenced-by-count":29,"title":["Drug-Induced Parkinsonism and Other Movement Disorders"],"prefix":"10.1017","volume":"17","author":[{"given":"R.T.","family":"Ross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"S0317167100030389_ref128","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)92126-8"},{"key":"S0317167100030389_ref127","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.57.669.445"},{"key":"S0317167100030389_ref125","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.1.97"},{"key":"S0317167100030389_ref123","first-page":">184","article-title":"Parkinson\u2019s disease on treatment with viskaldix","volume":"34","author":"Lervy","year":"1984","journal-title":"J R Coll Gen Pract"},{"key":"S0317167100030389_ref120","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197509042931008"},{"key":"S0317167100030389_ref118","first-page":"288","article-title":"Catatonia associated with phenylpropanoline overdose and fluphenazine treatment: case report","volume":"46","author":"Castellani","year":"1985","journal-title":"J Clin Psychiat"},{"key":"S0317167100030389_ref117","first-page":"156","author":"Gilman","year":"1985"},{"key":"S0317167100030389_ref116","first-page":"499","article-title":"Syndrome choreique et etat psychotique aigns provoques par une substance amphe-taminique","volume":"146","author":"Leys","year":"1985","journal-title":"Rev Neurol"},{"key":"S0317167100030389_ref115","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.29.12.1605"},{"key":"S0317167100030389_ref114","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.24.4.312"},{"key":"S0317167100030389_ref112","first-page":"44","article-title":"Tics with combined thioridazine-methylphenidate therapy: case report","volume":"47","author":"Casat","year":"1986","journal-title":"J Clin Psychiat"},{"key":"S0317167100030389_ref111","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.28.10.1041"},{"key":"S0317167100030389_ref110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1176\/ajp.141.1.118","article-title":"Parkinsonian side effects induced by a monamine oxidase inhibitor","volume":"141","author":"Teusink","year":"1984","journal-title":"Am J Psychiat"},{"key":"S0317167100030389_ref109","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1980.tb04805.x"},{"key":"S0317167100030389_ref108","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5452.33"},{"key":"S0317167100030389_ref107","first-page":"629","article-title":"Response of tardive and L-dopa-induced dyskinesias to antidepressants","volume":"14","author":"El-Awar","year":"1987","journal-title":"Can J Neuro Sci"},{"key":"S0317167100030389_ref105","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1176\/ajp.141.5.704","article-title":"Case report of tardive dyskinesia and parkinsonism associated with amoxapine therapy","volume":"141","author":"Thornton","year":"1984","journal-title":"Am J Psychiat"},{"key":"S0317167100030389_ref104","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1176\/ajp.139.11.1500","article-title":"Adverse reactions suggesting amoxapine-induced dopamine blockade","volume":"139","author":"Steele","year":"1982","journal-title":"Am J Psychiat"},{"key":"S0317167100030389_ref021","volume-title":"Medical Toxicology","author":"Ellenhorn","year":"1988"},{"key":"S0317167100030389_ref079","first-page":"1169","volume-title":"Scientific Approaches to Clinical Neurology","volume":"2","author":"Fahn","year":"1977"},{"key":"S0317167100030389_ref004","doi-asserted-by":"publisher","DOI":"10.1038\/311514a0"},{"key":"S0317167100030389_ref101","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)91344-6"},{"key":"S0317167100030389_ref076","first-page":"9","author":"Barbeau","year":"1985"},{"key":"S0317167100030389_ref106","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1176\/ajp.140.10.1358","article-title":"Case report of withdrawal dyskinesia associated with amoxapine","volume":"140","author":"Lesser","year":"1983","journal-title":"Am J Psychiat"},{"key":"S0317167100030389_ref040","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91516-2"},{"key":"S0317167100030389_ref089","first-page":"928","article-title":"Parkinsonism occurring during methyldopa therapy","volume":"95","author":"Strang","year":"1966","journal-title":"Can Med Assoc J"},{"key":"S0317167100030389_ref001","doi-asserted-by":"publisher","DOI":"10.1126\/science.6823561"},{"key":"S0317167100030389_ref020","first-page":"1414","volume-title":"Am J Psychiatry","volume":"135","author":"Flaherty","year":"1978"},{"key":"S0317167100030389_ref077","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90576-3"},{"key":"S0317167100030389_ref026","first-page":"737","article-title":"Le syndrome extra-pyramidal et diencephalique au cours des traitments au forgactil au serpasil","volume":"1","author":"Steck","year":"1954","journal-title":"Ann Med Psychol"},{"key":"S0317167100030389_ref033","first-page":"137","volume-title":"The Phenothiazines and Structurally Related Drugs","author":"Seeman","year":"1974"},{"key":"S0317167100030389_ref092","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410090117"},{"key":"S0317167100030389_ref121","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.34.1.20"},{"key":"S0317167100030389_ref049","first-page":"227","volume-title":"Handbook of Clinical Neurology","volume":"6","author":"Schwab","year":"1968"},{"key":"S0317167100030389_ref065","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198505303122203"},{"key":"S0317167100030389_ref050","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-196607000-00008"},{"key":"S0317167100030389_ref036","first-page":"180","article-title":"A study of drug-induced parkinsonism","volume":"24","author":"Stratas","year":"1963","journal-title":"Diseases of the Nervous System"},{"key":"S0317167100030389_ref122","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1981.tb02188.x"},{"key":"S0317167100030389_ref068","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.877545"},{"key":"S0317167100030389_ref051","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)92338-8"},{"key":"S0317167100030389_ref069","first-page":"167","article-title":"Aetiology of Parkinson\u2019s disease","volume":"1","author":"Blair","year":"1984","journal-title":"Lancet"},{"key":"S0317167100030389_ref062","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1983.tb03446.x"},{"key":"S0317167100030389_ref086","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1962.tb02331.x"},{"key":"S0317167100030389_ref015","first-page":"280","article-title":"Compendium of neuropsychopharmacology","volume":"2","author":"LaVerne","year":"1961","journal-title":"J Neuropsychiat"},{"key":"S0317167100030389_ref090","first-page":"473","article-title":"Neuroleptic-induced parkinsonism facilitated by alcohol","volume":"76","author":"Lutz","year":"1978","journal-title":"J Med Soc NJ"},{"key":"S0317167100030389_ref066","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91729-5"},{"key":"S0317167100030389_ref023","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1974.00490350041006"},{"key":"S0317167100030389_ref017","first-page":"105","volume-title":"Psychopharmacology","volume":"59","author":"Gerlach","year":"1978"},{"key":"S0317167100030389_ref025","first-page":"122","volume-title":"Pre- and postsynaptic receptors","author":"Bunney","year":"1975"},{"key":"S0317167100030389_ref031","first-page":"35","article-title":"Drug-induced changes in the release of 3monoamines from field stimulated rat brain slices","volume":"371","author":"Famebo","year":"1971","journal-title":"Acta Physiol Scand"},{"key":"S0317167100030389_ref075","doi-asserted-by":"publisher","DOI":"10.5271\/sjweh.2549"},{"key":"S0317167100030389_ref046","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/003591576405700835","article-title":"An apparently irreversible syndrome of abnormal movements following phenothiazine medication","volume":"57","author":"Hunter","year":"1964","journal-title":"Proc Roy Soc Med"},{"key":"S0317167100030389_ref047","doi-asserted-by":"publisher","DOI":"10.1159\/000102857"},{"key":"S0317167100030389_ref053","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)90937-8"},{"key":"S0317167100030389_ref124","first-page":"509","article-title":"Reversible parkinsonism related to meperidine","volume":"8","author":"Lieberman","year":"1985","journal-title":"N Engl J Med"},{"key":"S0317167100030389_ref012","doi-asserted-by":"publisher","DOI":"10.1038\/1801200a0"},{"key":"S0317167100030389_ref067","first-page":"455","article-title":"Uptake of MPP by dopamine neurons explains selectivity of parkinsonian-inducing neurotoxin","volume":"10","author":"Javitch","year":"1985","journal-title":"Eur J Pharm"},{"key":"S0317167100030389_ref083","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.4.728"},{"key":"S0317167100030389_ref102","first-page":"814","article-title":"Amoxapine in experimental psycho pharmacology: a neuroleptic or an antidepressant?","volume":"29","author":"Chermat","year":"1979","journal-title":"Arzneim Forsch"},{"key":"S0317167100030389_ref081","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.127.5.690"},{"key":"S0317167100030389_ref064","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.7.2173"},{"key":"S0317167100030389_ref094","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410130421"},{"key":"S0317167100030389_ref093","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410120307"},{"key":"S0317167100030389_ref060","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.16.4.213"},{"key":"S0317167100030389_ref032","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.119.10.995"},{"key":"S0317167100030389_ref029","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0022-3565(25)29297-7","article-title":"Feedback control of dopamine synthesis in dopaminergic terminals of the rat striatum","volume":"192","author":"Javoy","year":"1972","journal-title":"J Pharmacol ExpTher"},{"key":"S0317167100030389_ref063","doi-asserted-by":"publisher","DOI":"10.1126\/science.6332378"},{"key":"S0317167100030389_ref028","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0026-895X(25)14859-1","article-title":"End-product inhibition of tyrosine hydroxylase as a possible mechanism for regulation of norephinephrine synthesis","volume":"3","author":"Spector","year":"1967","journal-title":"Mol Pharmacol"},{"key":"S0317167100030389_ref034","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1176\/ajp.133.6.703","article-title":"Low urinary dopamine and prediction of phenothiazine induced parkinsonism: a preliminary report","volume":"133","author":"Crowley","year":"1976","journal-title":"Am J Psychiatry"},{"key":"S0317167100030389_ref027","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0031-6997(25)06931-5","article-title":"The membrane actions of anesthetics and tranquilizers","volume":"24","author":"Seeman","year":"1972","journal-title":"Pharmacol Rev"},{"key":"S0317167100030389_ref011","first-page":"112","article-title":"Parkinsonism and brain tumor","volume":"70","author":"Marguilies","year":"1953","journal-title":"Arch Neurol Psychiat"},{"key":"S0317167100030389_ref113","first-page":"555","author":"Gilman","year":"1980"},{"key":"S0317167100030389_ref098","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(72)90190-6"},{"key":"S0317167100030389_ref042","first-page":"506","article-title":"Similitude des accidents nerveux de la prochorperazine avec certains troubles post-encephalitiques","volume":"115","author":"Delay","year":"1957","journal-title":"Ann Med Psychol"},{"key":"S0317167100030389_ref010","first-page":"151","article-title":"A large kindred with autosomal dominant Parkinson\u2019s disease","volume":"24","author":"Golbe","year":"1988","journal-title":"Ann Neurol"},{"key":"S0317167100030389_ref022","doi-asserted-by":"publisher","DOI":"10.1007\/BF00427747"},{"key":"S0317167100030389_ref095","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410080206"},{"key":"S0317167100030389_ref059","doi-asserted-by":"publisher","DOI":"10.1038\/311464a0"},{"key":"S0317167100030389_ref078","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1986.tb02820.x"},{"key":"S0317167100030389_ref002","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.7.949"},{"key":"S0317167100030389_ref035","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.116.11.1022"},{"key":"S0317167100030389_ref003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198402233100810"},{"key":"S0317167100030389_ref005","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410160303"},{"key":"S0317167100030389_ref056","doi-asserted-by":"publisher","DOI":"10.1126\/science.6823561"},{"key":"S0317167100030389_ref103","first-page":"657","article-title":"Amoxapine: a clinical evaluation in depressive syndromes","volume":"14","author":"Charalampous","year":"1972","journal-title":"Curr Ther Res"},{"key":"S0317167100030389_ref030","first-page":"200","article-title":"Antipsychotic drug actions: a clue to the neuropathology of schizophrenia","volume":"32","author":"Matthysee","year":"1973","journal-title":"Fed Proc"},{"key":"S0317167100030389_ref006","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1056\/NEJM198510313131813","article-title":"The clinical syndrome of striatal dopamine deficiency: parkinsonism induced by MPTP","volume":"313","author":"Eldridge","year":"1985","journal-title":"N Engl J Med"},{"key":"S0317167100030389_ref019","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1977.01770200085010"},{"key":"S0317167100030389_ref008","first-page":"5","volume-title":"Pathogenesis and Treatment of Parkinsonism","author":"Kurland","year":"1958"},{"key":"S0317167100030389_ref009","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100026664"},{"key":"S0317167100030389_ref013","first-page":"288","volume-title":"Handbook of Parkinson\u2019s Disease","author":"Gordon","year":"1987"},{"key":"S0317167100030389_ref014","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1958.tb10268.x"},{"key":"S0317167100030389_ref016","first-page":"961","article-title":"Tardive dyskinesia with low-dose, short-term, neuroleptic therapy","volume":"33","author":"Stimmel","year":"1976","journal-title":"Am J Hosp Pharm"},{"key":"S0317167100030389_ref018","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1056\/NEJM198109103051116","article-title":"Prolonged adverse effects of haloperidol in normal subjects. Letter","volume":"305","author":"Anderson","year":"1981","journal-title":"N Engl J Med"},{"key":"S0317167100030389_ref024","first-page":"49","volume-title":"Pre- and postsynaptic receptors","author":"Carlsson","year":"1975"},{"key":"S0317167100030389_ref037","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-2511-6_6"},{"key":"S0317167100030389_ref038","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1982.00510220042009"},{"key":"S0317167100030389_ref126","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1971.03180330074022"},{"key":"S0317167100030389_ref039","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.293.6552.957"},{"key":"S0317167100030389_ref043","first-page":"513","volume-title":"Rev Neurol","volume":"27","author":"Marie","year":"1920"},{"key":"S0317167100030389_ref044","first-page":"546","article-title":"Deux nouveaux cas de movements involuntaries post-encephalitiques: a localisation exclusivement lingulo-facio masticatrice","volume":"44","author":"Marie","year":"1920","journal-title":"Bull et mem Soc med d hop de Par"},{"key":"S0317167100030389_ref045","first-page":"661","article-title":"Un nouveau cas de localisation facio-mastica-trice du syndrome excito-moteur tardif de l\u2019encephalite epidemique avec manifestations de tic douloureux de la face","volume":"44","author":"Marie","year":"1920","journal-title":"Bull et mem Soc med d hop de Par"},{"key":"S0317167100030389_ref052","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.135.5.619-a"},{"key":"S0317167100030389_ref054","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.1.37"},{"key":"S0317167100030389_ref007","first-page":"27","article-title":"Paralysis agitans mortality in England and Wales 1885\u20131962","volume":"20","author":"Duvoisin","year":"1966","journal-title":"Br J Prev Soc Med"},{"key":"S0317167100030389_ref055","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(79)90006-4"},{"key":"S0317167100030389_ref057","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM198308043090511","article-title":"Parkinson\u2019s disease in a chemist working with l-methyl-4-phenyl-l,2,5,6-tetrahydropyridine","volume":"309","author":"Langston","year":"1983","journal-title":"N Engl J Med"},{"key":"S0317167100030389_ref048","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1017121"},{"key":"S0317167100030389_ref058","doi-asserted-by":"publisher","DOI":"10.1038\/311467a0"},{"key":"S0317167100030389_ref061","first-page":"17","article-title":"Neuro-melanin in manganese-exposed primates","volume":"6","author":"Gupta","year":"1980","journal-title":"Toxicology"},{"key":"S0317167100030389_ref070","first-page":"231","article-title":"The role of tetrahydrobiopterin in neurological disease","volume":"25","author":"Leeming","year":"1981","journal-title":"J Ment Defic Res"},{"key":"S0317167100030389_ref071","doi-asserted-by":"publisher","DOI":"10.1039\/p29750000245"},{"key":"S0317167100030389_ref119","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100029292"},{"key":"S0317167100030389_ref072","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410200403"},{"key":"S0317167100030389_ref073","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)91111-0"},{"key":"S0317167100030389_ref074","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-197803000-00010"},{"key":"S0317167100030389_ref080","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)92325-X"},{"key":"S0317167100030389_ref082","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1982.00510240006002"},{"key":"S0317167100030389_ref084","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.36.8.1147-b"},{"key":"S0317167100030389_ref085","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.4.728-a"},{"key":"S0317167100030389_ref087","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5336.1001"},{"key":"S0317167100030389_ref088","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5402.168"},{"key":"S0317167100030389_ref091","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1976.03270220042034"},{"key":"S0317167100030389_ref096","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000115593","article-title":"Parkinsonian syndrome after methanol intoxication","volume":"22","author":"Ley","year":"1983","journal-title":"Eur Neurol"},{"key":"S0317167100030389_ref097","first-page":"165","article-title":"Acute lithium-induced parkinsonism precipitated by liquid protein diet","volume":"75","author":"Lutz","year":"1978","journal-title":"J Med Soc NJ"},{"key":"S0317167100030389_ref099","doi-asserted-by":"publisher","DOI":"10.2337\/diab.17.8.522"},{"key":"S0317167100030389_ref100","first-page":"124","article-title":"A parkinson-like syndrome as side effect of chemotherapy with vincristine and adriamycin in a child with acute leukaemia","volume":"31","author":"Boranic","year":"1979","journal-title":"Biomedicine"}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167100030389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T07:13:57Z","timestamp":1749021237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167100030389\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,5]]},"references-count":127,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1990,5]]}},"alternative-id":["S0317167100030389"],"URL":"https:\/\/doi.org\/10.1017\/s0317167100030389","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"value":"0317-1671","type":"print"},{"value":"2057-0155","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,5]]}}}